Importance Corticosteroids improve strength and function in boys with Duchenne muscular
dystrophy. However, there is uncertainty regarding the optimum regimen and dosage …

Despite corticosteroids being the only treatment documented to improve strength and
function in boys with Duchenne muscular dystrophy (DMD) corticosteroid prescription is …

Objective To evaluate clinical outcomes and steroid side effects in a cohort of patients with
Duchenne muscular dystrophy (DMD) treated with long-term daily glucocorticoid therapy …

In 2005, the American Academy of Neurology and the Child Neurology Society published a
practice parameter, based primarily on studies that involved 6 to 18 months of treatment …

Introduction In this study we characterized disease progression over 48 weeks among boys
receiving deflazacort vs prednisone/prednisolone placebo arm treatment in two recent …

Duchenne muscular dystrophy is the most common and most severe form of childhood
muscular dystrophies, resulting in early loss of ambulation between the ages of 7 and 13 …

Background: The Quality Standards Subcommittee of the American Academy of Neurology
and the Practice Committee of the Child Neurology Society develop practice parameters as …

Introduction: Corticosteroid treatment is the standard of care in Duchenne muscular
dystrophy (DMD), but the optimal age to initiate treatment and dosage pattern remain a …

Objective: To update the 2005 American Academy of Neurology (AAN) guideline on
corticosteroid treatment of Duchenne muscular dystrophy (DMD). Methods: We …

Daily prednisone improves strength in boys with Duchenne muscular dystrophy, but side
effects are almost universal. We used a different dosing regimen of prednisone to determine …